BioSpace News Archive

FDA

Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Systemic Lupus Erythematosus

Landos Biopharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for LABP-104 or the treatment of systemic lupus erythematosus (SLE).

October 11, 2021
·
7 min read
Business

Cellares Appoints John Tomtishen as Vice President of Operations

Cellares Corporation, today announced the appointment of John Tomtishen as Vice President of Operations.

October 11, 2021
·
4 min read
Deals

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

Pacira BioSciences, Inc. and Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced a definitive agreement pursuant to which Pacira will acquire Flexion for $8.50 per share in cash, plus one non-tradeable contingent value right (CVR) worth up to $8.00 per share in cash.

October 11, 2021
·
21 min read
FDA

Protagonist Therapeutics Announces Removal of FDA Clinical Hold on the Rusfertide Clinical Development Program

All ongoing clinical trials of rusfertide to resume dosing Phase 3 registrational trial planned to commence in the first quarter of 2022 Conference call scheduled for today at 8:00 A.M. ET

October 11, 2021
·
6 min read
Lone Star Bio

Movair Announces Commercial Launch of Luisa Life Supporting Ventilator with High-Flow Oxygen Therapy

Movair today announced the U.S. commercial launch of Luisa, an advanced ventilator intended for use in homes, institutions, hospitals or portable applications for both invasive and non-invasive ventilation.

October 11, 2021
·
5 min read
BioMidwest

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

PsyBio Therapeutics Corp. today announced that Evan Levine , CEO and Chairman of PsyBio, will present at the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on Thursday, October 14th at 10:30 a.m. ET.

October 11, 2021
·
1 min read
BioMidwest

Wesana Health to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

Wesana Health Holdings Inc. today announced that Daniel Carcillo, CEO of Wesana Health, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

October 11, 2021
·
7 min read
Business

Reneo Pharmaceuticals Appoints Ashley Hall as Chief Development Officer

Reneo Pharmaceuticals, Inc. today announced the appointment of Ashley F. Hall, JD, to the position of Chief Development Officer.

October 11, 2021
·
4 min read
Business

Nautilus Biotechnology to Announce Third Quarter of Fiscal Year 2021 Financial Results on November 2, 2021

Nautilus Biotechnology, Inc. today announced it will report financial results for the third quarter of fiscal year 2021 before market open on Tuesday, November 2nd, 2021.

October 11, 2021
·
1 min read
Pharm Country

Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer

Athenex today announced that it recently held a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for oral paclitaxel and encequidar (Oral Paclitaxel) in metastatic breast cancer (mBC).

October 11, 2021
·
4 min read